
The Death of MONA in ACS: Part I – Morphine
…For More Thoughts on This Topic Checkout: Ryan Radecki at EM Literature of Note: Yes, Let MONA Fade Away Rory Spiegel at EM NERD (EMCrit): The Case of the Inconsequential…
…For More Thoughts on This Topic Checkout: Ryan Radecki at EM Literature of Note: Yes, Let MONA Fade Away Rory Spiegel at EM NERD (EMCrit): The Case of the Inconsequential…
Background: The first report for supplemental oxygen for angina was in 1900, and since then oxygen therapy has been a commonly used treatment of patients with ST-Elevation Myocardial Infarction (STEMI)….
Background: Nitroglycerin is a first line agent in the treatment of ACS. The physiologic basis for it’s use rests on it’s ability to promote coronary vasodilation resulting in increased blood…
Background: Aspirin is the most widely used antiplatelet agent in acute coronary syndromes. The bulk of the evidence for this came from the second international study of infarct survival (ISIS-2)…
…an opiate should not delay interventions as the cause of pain has been masked, and not treated. Have we have seen the death of MONA in ACS…Maybe. In a previous…
© 2022 REBEL EM. All rights reserved. | Disclaimer | Website by Innov8 Place.